A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) PatientsSara Bringhen, Mario Boccadoro, Alessandra Larocca et al.|Blood|2016Cited by 7